Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5a35f1bccac8690e3fe5caf89045030 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-11001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-351 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-344 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-31 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-641 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-549 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-552 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-11001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-111 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04 |
filingDate |
2020-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9c3c47d669fbc9af8471fdf18da7b9e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f732a5b3ee73cea3128e0f1a870798d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c8d282dcc0b4eb2494ad6a6eab1bb8b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26ade7526d78e2d99f3c90be5f9b4627 |
publicationDate |
2021-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-3156667-A1 |
titleOfInvention |
OLIGONUCLEOTIDES INCLUDING NUCLEOSIDE ANALOGS |
abstract |
Disclosed herein are siRNA compositions that contain gemcitabine (GEM) in place of cytosine moieties in the siRNA sequence. The invention also relates to pharmaceutical compositions containing these siRNA molecules and methods of using the compositions to treat diseases such as cancer. |
priorityDate |
2019-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |